A new production of our patented yeast is being produced by Jästbolaget ahead of the launch of our patented anti-aging product AgeViva™ in Q1 2025.

Our trademark AgeViva™ was approved Nov 29.

Trevor Archer, Thomas Lenz and Roger Karlsson visited Sapienza University Nov 25-28. The team at Sapienza with professor Rita Businaro presented new results in antiaging studies. The presentation showed new very positive and strong study results for the important hallmarks of longevity/antiaging: autophagy, anti-inflammageing and anti-oxidative stress

Trevor Archer and Thomas Lenz, has participated in the 30th annual which took place this year in Stockholm November 4-6. BIO-Europé is one of the top pharma events in Europe. The BIO-Europe program explores the impact of the Swedish approach, embodied by an openness to collaboration, has had on biotech innovation, and addresses the latest… Read More »30th annual BIO-Europe

Milmed Unico’s new subsidiary Longevience AB is registred the 11th of October. Everything related to longevity and antiaging will be in our new company.

The 18th of June Milmed Unico AB submitted a new patent application, “YEAST FOR PROMOTING LONGEVITY AND/OR ANTIAGING”. We believe that there are good conditions now to get this application approved, because the patent have very strong scientic results from our antiaging studies. There is both in vivo and in vitro studies performed at Sapienza… Read More »New patent application submitted